Kano Therapeutics Inc. — Form D
Kano Therapeutics Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-05-20. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-05-20
- Form: D
- Accession: 0002023721-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $5.0M
- Investors: 4
- Date of first sale: 2024-05-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-513745
Issuer
- Name: Kano Therapeutics Inc.
- CIK: 0002023721
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 238 MAIN STREET, CAMBRIDGE, MA, 02142
- Phone: 6174859448
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Ann DeWitt | Director | Woburn, MA |
| Floris Engelhardt | Director | Cambridge, MA |
| John Vroom | Director | Cambridge, MA |
| Floris Engelhardt | Executive Officer | Cambridge, MA |
More